Atlas Trials

Extension Study for Patients Who Have Participated in a BMN 701 Study

Clinical trial NCT01435772 · TERMINATED

Trial details

NCT number
NCT01435772
Sponsor
BioMarin Pharmaceutical
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Pompe Disease
Start date
2011-08-15
Primary completion
2016-09-09
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.